Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
YU9dkXRhVSZB2k8w
